Jason Wittes
Stock Analyst at Roth Capital
(2.68)
# 2,163
Out of 5,090 analysts
61
Total ratings
49.06%
Success rate
4.61%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals | Initiates: Buy | $40 | $9.93 | +302.82% | 1 | Sep 4, 2025 | |
| SYK Stryker | Maintains: Buy | $405 → $456 | $364.02 | +25.27% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $1.70 | +841.18% | 2 | Mar 21, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $2.83 | +465.37% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $15.90 | +38.36% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $94.57 | -23.87% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $7.06 | +55.81% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $91.10 | +26.23% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $12.35 | +191.50% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $7.93 | +38.71% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.05 | +852.38% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $84.53 | +18.30% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.41 | +107.47% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.99 | +813.24% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $27.02 | +177.57% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $21.45 | +2.56% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $94.28 | +27.28% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $141.68 | +45.40% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $177.72 | -18.41% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $17.27 | -13.14% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $12.11 | +1,551.53% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $30.76 | -15.47% | 1 | Feb 22, 2017 |
ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $9.93
Upside: +302.82%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $364.02
Upside: +25.27%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $1.70
Upside: +841.18%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $2.83
Upside: +465.37%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $15.90
Upside: +38.36%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $94.57
Upside: -23.87%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $7.06
Upside: +55.81%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $91.10
Upside: +26.23%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $12.35
Upside: +191.50%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.93
Upside: +38.71%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.05
Upside: +852.38%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $84.53
Upside: +18.30%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.41
Upside: +107.47%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $0.99
Upside: +813.24%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $27.02
Upside: +177.57%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $21.45
Upside: +2.56%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $94.28
Upside: +27.28%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $141.68
Upside: +45.40%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $177.72
Upside: -18.41%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $17.27
Upside: -13.14%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $12.11
Upside: +1,551.53%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $30.76
Upside: -15.47%